United States
The United States is the largest market for molecular diagnostics globally, driven by a well-developed healthcare system, significant investments in R&D, and a high demand for advanced diagnostic technologies. The country’s market is characterized by a strong focus on early disease detection, particularly in cancer, infectious diseases, and genetic disorders. The growing...
English
Arabic
Français
Español
Português
Türkçe
Dutch
Italiano
Russian
Romaian